@ARTICLE{
author={Robak Tadeusz,Windyga Jerzy,Trelinski Jacek,Prondzinski Mario von Depka,Giagounidis Aristoteles,Doyen Chantal,Janssens Ann,Teresa Alvarez-Roman Maria,Jarque Isidro,Loscertales Javier,Perez-Rus Gloria,Hellmann Andrzej,Jedrzejczak Wieslaw Wiktor,Kuliczkowski Kazimierz,Golubovic Lana M,Celeketic Dusica C,Cucuianu Andrei,Gheorghita Emanuil,Lazaroiu Mihaela,Shpilberg Ofer,Attias Dina,Karyagina Elena,Svetlana Kalinina,Vilchevska Kateryna,Cooper Nichola,Talks Kate,Prabhu Mukhyaprana,Sripada Prasad,Bharadwaj TPR,Naested Henrik,Skartved Niels JO,Frandsen Torben P,Flensburg Mimi F,S-Andersen Peter,Petersen Jorgen B},
year={2012},
title={Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia},
journal={BLOOD},
volume={120},
number={18},
pages={3670-3676},
document_type={Article},
} 

@ARTICLE{
author={Robak Tadeusz,...,Celeketic Dusica C,...,(broj koautora 32)},
year={2011},
title={Final Results From a Phase II Trial with the First in Class Recombinant Polyclonal Antibody Product Rozrolimupab in Primary Immune Thrombocytopenia},
journal={BLOOD},
volume={118},
number={21},
pages={245-245},
document_type={Meeting Abstract},
}